Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
POINT Biopharma Global Inc. | Director | Stock Option (Right to Buy) | 80.5K | Jun 13, 2023 | Direct | ||
Aligos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 60K | Jun 27, 2024 | Direct | ||
ACHIEVE LIFE SCIENCES, INC. | Director | Stock Option (right to buy) | 31.5K | Jan 22, 2024 | Direct | ||
DELCATH SYSTEMS, INC. | Director | Stock Option (right to buy) | 22.5K | May 23, 2024 | Direct |